digital desk, London. American pharmaceutical company Moderna has said that it is working on making a vaccine that will show its effect in both Kovid and flu cases. The vaccine could be ready as early as next year.
The Daily Mail reported that the vaccine would be more convenient for patients, according to the company’s UK head Darius Hughes, as it requires less visits to a medical center and also lowers the cost of the NHS for vaccination.
Hughes has been quoted as saying that an effective vaccine against Kovid and flu could be available by the winter of 2023.
Last year, the NHS reassured patients that getting vaccinated against the flu and COVID at the same time did not affect the immune response.
Moderna is also currently developing a vaccine specifically to combat Omicron. The preliminary phase data regarding its impact is likely to come within the next two weeks.
Moderna also hopes to create a vaccine that tackles COVID, influenza and respiratory syncytial virus (RSV), which usually cause mild symptoms, but can be severe, the report said. Especially, for babies and older adults.
“After getting the right COVID vaccine for the Omicron variant, our number one priority for 2022 is to step up our flu and RSV programs and see if we can get a combination, single-dose respiratory vaccine,” Hughes said. Huh.
Hughes said the vaccine would immensely benefit the NHS, and all immunization services and patients.
According to the report, he said that this vaccine will be first given to those who were offered the flu vaccine before the pandemic and who are over 65 years of age and have been ill for a long time.
Stay Tuned to Janta Yojana for more Latest & Breaking Indian News.